176 related articles for article (PubMed ID: 10543502)
21. How safe is the port access technique in minimally invasive coronary artery bypass grafting?
Dogan S; Graubitz K; Aybek T; Khan MF; Kessler P; Moritz A; Wimmer-Greinecker G
Ann Thorac Surg; 2002 Nov; 74(5):1537-43; discussion 1543. PubMed ID: 12440605
[TBL] [Abstract][Full Text] [Related]
22. Use of modified ultrafiltration in adults undergoing coronary artery bypass grafting is associated with inflammatory modulation and less postoperative blood loss: a randomized and controlled study.
Torina AG; Silveira-Filho LM; Vilarinho KA; Eghtesady P; Oliveira PP; Sposito AC; Petrucci O
J Thorac Cardiovasc Surg; 2012 Sep; 144(3):663-70. PubMed ID: 22578899
[TBL] [Abstract][Full Text] [Related]
23. Myocardium is a major source of proinflammatory cytokines in patients undergoing cardiopulmonary bypass.
Wan S; DeSmet JM; Barvais L; Goldstein M; Vincent JL; LeClerc JL
J Thorac Cardiovasc Surg; 1996 Sep; 112(3):806-11. PubMed ID: 8800171
[TBL] [Abstract][Full Text] [Related]
24. [Changes in content of inflammatory cytokines and troponin I in peri-operative periods of coronary artery bypass grafting with or without cardiopulmonary bypass].
Huang ZY; Yao B; Jiang HY; Xu MX
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2005 Mar; 17(3):168-70. PubMed ID: 15760531
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of systemic inflammatory response in cardiovascular surgery via interleukin-6, interleukin-8, and neopterin.
Uyar IS; Onal S; Uysal A; Ozdemir U; Burma O; Bulut V
Heart Surg Forum; 2014 Feb; 17(1):E13-7. PubMed ID: 24631985
[TBL] [Abstract][Full Text] [Related]
26. Antiinflammatory effects of colforsin daropate hydrochloride, a novel water-soluble forskolin derivative.
Hayashida N; Chihara S; Tayama E; Takaseya T; Enomoto N; Kawara T; Aoyagi S
Ann Thorac Surg; 2001 Jun; 71(6):1931-8. PubMed ID: 11426771
[TBL] [Abstract][Full Text] [Related]
27. Factors affecting post minimally invasive direct coronary artery bypass grafting incidence of myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting and mortality of cardiac origin.
Kofidis T; Gerd Paeschke H; Lichtenberg A; Emmert M; Woitek F; Didilis V; Haverich A; Klima U
Interact Cardiovasc Thorac Surg; 2009 Jan; 8(1):49-53. PubMed ID: 18786942
[TBL] [Abstract][Full Text] [Related]
28. A Comparison of Inflammatory Responses Between Robotically Enhanced Coronary Artery Bypass Grafting and Conventional Coronary Artery Bypass Grafting: Implications for Hybrid Revascularization.
Leyvi G; Vivek K; Sehgal S; Warrick A; Moncada KA; Shilian N; Leff JD; Michler RE; DeRose JJ
J Cardiothorac Vasc Anesth; 2018 Feb; 32(1):251-258. PubMed ID: 28807577
[TBL] [Abstract][Full Text] [Related]
29. Comparison of the effects of pulsatile cardiopulmonary bypass, non-pulsatile cardiopulmonary bypass and off-pump coronary artery bypass grafting on the inflammatory response and S-100beta protein.
Bayram H; Erer D; Iriz E; Zor MH; Gulbahar O; Ozdogan ME
Perfusion; 2012 Jan; 27(1):56-64. PubMed ID: 22002967
[TBL] [Abstract][Full Text] [Related]
30. Evidence for inflammatory responses of the lungs during coronary artery bypass grafting with cardiopulmonary bypass.
Massoudy P; Zahler S; Becker BF; Braun SL; Barankay A; Meisner H
Chest; 2001 Jan; 119(1):31-6. PubMed ID: 11157581
[TBL] [Abstract][Full Text] [Related]
31. Minimally invasive direct coronary bypass versus cardiopulmonary technique: angiographic comparison.
Lazzara RR; Kidwell FE
Ann Thorac Surg; 1999 Feb; 67(2):500-3. PubMed ID: 10197678
[TBL] [Abstract][Full Text] [Related]
32. Influenza Vaccination Blunts the Inflammatory Response in Patients Undergoing Cardiopulmonary Bypass.
Atoui R; Ebrahim F; Saroka K; Mireau J; McElhaney JE; Hare GMT
Ann Thorac Surg; 2021 Jun; 111(6):1923-1930. PubMed ID: 33038338
[TBL] [Abstract][Full Text] [Related]
33. Plasma levels of immunoinhibitory cytokines interleukin-10 and transforming growth factor-beta in patients undergoing coronary artery bypass grafting.
Sablotzki A; Welters I; Lehmann N; Menges T; Görlach G; Dehne M; Hempelmann G
Eur J Cardiothorac Surg; 1997 Apr; 11(4):763-8. PubMed ID: 9151050
[TBL] [Abstract][Full Text] [Related]
34. Inflammatory response and myocardial injury following coronary artery bypass grafting with or without cardiopulmonary bypass.
Czerny M; Baumer H; Kilo J; Lassnigg A; Hamwi A; Vukovich T; Wolner E; Grimm M
Eur J Cardiothorac Surg; 2000 Jun; 17(6):737-42. PubMed ID: 10856869
[TBL] [Abstract][Full Text] [Related]
35. Prediction of clinical outcome after cardiac surgery: the role of cytokines, endotoxin, and anti-endotoxin core antibodies.
Rothenburger M; Soeparwata R; Deng MC; Schmid C; Berendes E; Tjan TD; Wilhelm MJ; Erren M; Böcker D; Scheld HH
Shock; 2001; 16 Suppl 1():44-50. PubMed ID: 11770033
[TBL] [Abstract][Full Text] [Related]
36. Minimally invasive extracorporeal circulation improves quality of life after coronary artery bypass grafting.
Anastasiadis K; Antonitsis P; Kostarellou G; Kleontas A; Deliopoulos A; Grosomanidis V; Argiriadou H
Eur J Cardiothorac Surg; 2016 Dec; 50(6):1196-1203. PubMed ID: 27307483
[TBL] [Abstract][Full Text] [Related]
37. Beating heart revascularization with or without cardiopulmonary bypass: evaluation of inflammatory response in a prospective randomized study.
Wan IY; Arifi AA; Wan S; Yip JH; Sihoe AD; Thung KH; Wong EM; Yim AP
J Thorac Cardiovasc Surg; 2004 Jun; 127(6):1624-31. PubMed ID: 15173716
[TBL] [Abstract][Full Text] [Related]
38. Monocyte hyporesponsiveness and Toll-like receptor expression profiles in coronary artery bypass grafting and its clinical implications for postoperative inflammatory response and pneumonia: An observational cohort study.
Flier S; Concepcion AN; Versteeg D; Kappen TH; Hoefer IE; de Lange DW; Pasterkamp G; Buhre WF
Eur J Anaesthesiol; 2015 Mar; 32(3):177-88. PubMed ID: 25405275
[TBL] [Abstract][Full Text] [Related]
39. Inflammatory cytokines and soluble receptors after coronary artery bypass grafting.
Wei M; Kuukasjärvi P; Laurikka J; Pehkonen E; Kaukinen S; Laine S; Tarkka M
Cytokine; 2001 Aug; 15(4):223-8. PubMed ID: 11563882
[TBL] [Abstract][Full Text] [Related]
40. Attenuation of cardiopulmonary bypass-derived inflammatory reactions reduces myocardial reperfusion injury in cardiac operations.
Sawa Y; Shimazaki Y; Kadoba K; Masai T; Fukuda H; Ohata T; Taniguchi K; Matsuda H
J Thorac Cardiovasc Surg; 1996 Jan; 111(1):29-35. PubMed ID: 8551786
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
